Fitzroy W. Dawkins
- Hematology top 0.5%
- Iron Metabolism and Disorders 22
- Chronic Myeloid Leukemia Treatments 4
- Genetics top 1%
- Hemoglobinopathies and Related Disorders 21
- Chronic Lymphocytic Leukemia Research 6
- Nutrition and Dietetics top 1%
- Trace Elements in Health 9
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 4
- Immunology top 10%
-
- Folate and B Vitamins Research 8
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Gordon D. McLarenPaul C. AdamsDavid M. ReboussinJames C. BartonRonald T. ActonVictor R. GordeukMark SpeechleyPhyliss Sholinsky
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Fitzroy W. Dawkins
48 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Hematology 1.3k
- Genetics 977
- Nutrition and Dietetics 606
- Oncology 704
- Immunology 425
Countries citing papers authored by Fitzroy W. Dawkins
This map shows the geographic impact of Fitzroy W. Dawkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fitzroy W. Dawkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fitzroy W. Dawkins more than expected).
Fields of papers citing papers by Fitzroy W. Dawkins
This network shows the impact of papers produced by Fitzroy W. Dawkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fitzroy W. Dawkins. The network helps show where Fitzroy W. Dawkins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fitzroy W. Dawkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 173 | |
| 2 | 2018 | 87 | |
| 3 | 2013 | 11 | |
| 4 | Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerbreakdown → | 2012 | 336 |
| 5 | 2008 | 47 | |
| 6 | 2007 | 6 | |
| 7 | 2007 | 41 | |
| 8 | 2007 | 7 | |
| 9 | 2007 | 61 | |
| 10 | 2006 | 43 | |
| 11 | 2006 | 7 | |
| 12 | Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C. | 2006 | 1 |
| 13 | 2005 | 59 | |
| 14 | Hemochromatosis and Iron-Overload Screening in a Racially Diverse Populationbreakdown → | 2005 | 547 |
| 15 | 2005 | 103 | |
| 16 | 2005 | 25 | |
| 17 | 2005 | 26 | |
| 18 | 2003 | 110 | |
| 19 | 2002 | 40 | |
| 20 | 1997 | 24 |
About Fitzroy W. Dawkins
Fitzroy W. Dawkins is a scholar working on Hematology, Genetics and Nutrition and Dietetics, having authored 48 papers that have together received 2.5k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (22 papers), Hemoglobinopathies and Related Disorders (21 papers), Trace Elements in Health (9 papers), Folate and B Vitamins Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (977 citations) and Nutrition and Dietetics (606 citations). Fitzroy W. Dawkins has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Gordon D. McLaren, Paul C. Adams, David M. Reboussin, James C. Barton, Ronald T. Acton, Victor R. Gordeuk, Mark Speechley, Phyliss Sholinsky, John H. Eckfeldt and Christine E. McLaren. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.